The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Global Autoimmune Disease Treatment Market Research Report 2024
Synopsis
Autoimmune diseases is a body’s hyperactive immune response against the substances and tissues normally present in the body. Autoimmune diseases are more commonly caused by genetic, infectious or environmental factors.
The global Autoimmune Disease Treatment market was valued at US$ 98160 million in 2023 and is anticipated to reach US$ 119350 million by 2030, witnessing a CAGR of 2.4% during the forecast period 2024-2030.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
This report aims to provide a comprehensive presentation of the global market for Autoimmune Disease Treatment, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Autoimmune Disease Treatment.
Report Scope
The Autoimmune Disease Treatment market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Autoimmune Disease Treatment market comprehensively. Regional market sizes, concerning products by Type, by Sale Channel, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Autoimmune Disease Treatment companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Sale Channel, and by regions.
Market Segmentation
By Company
Abbott Laboratories
Active Biotech
Eli Lilly
Bristol-Myers Squibb
AstraZeneca plc
Pfizer
Biogen Idec
Lupin Limited
GlaxoSmithKline
Amgen
4SC AG
F. Hoffmann-La Roche Ltd.
AutoImmune Inc
Johnson & Johnson
Bayer
Segment by Type
Immunosuppressant’s
Anti-Inflammatory Drugs
Corticosteroids
Nonsteroidal Anti-inflammatory Drugs
Biologics
Segment by Sale Channel
Hospitals
Clinics
Drug Stores
Other
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Sale Channel, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Autoimmune Disease Treatment companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Sale Channel, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
Autoimmune diseases is a body’s hyperactive immune response against the substances and tissues normally present in the body. Autoimmune diseases are more commonly caused by genetic, infectious or environmental factors.
The global Autoimmune Disease Treatment market was valued at US$ 98160 million in 2023 and is anticipated to reach US$ 119350 million by 2030, witnessing a CAGR of 2.4% during the forecast period 2024-2030.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
This report aims to provide a comprehensive presentation of the global market for Autoimmune Disease Treatment, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Autoimmune Disease Treatment.
Report Scope
The Autoimmune Disease Treatment market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Autoimmune Disease Treatment market comprehensively. Regional market sizes, concerning products by Type, by Sale Channel, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Autoimmune Disease Treatment companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Sale Channel, and by regions.
Market Segmentation
By Company
Abbott Laboratories
Active Biotech
Eli Lilly
Bristol-Myers Squibb
AstraZeneca plc
Pfizer
Biogen Idec
Lupin Limited
GlaxoSmithKline
Amgen
4SC AG
F. Hoffmann-La Roche Ltd.
AutoImmune Inc
Johnson & Johnson
Bayer
Segment by Type
Immunosuppressant’s
Anti-Inflammatory Drugs
Corticosteroids
Nonsteroidal Anti-inflammatory Drugs
Biologics
Segment by Sale Channel
Hospitals
Clinics
Drug Stores
Other
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Sale Channel, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Autoimmune Disease Treatment companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Sale Channel, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
Index1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Autoimmune Disease Treatment Market Size Growth Rate by Type: 2019 VS 2023 VS 2030
1.2.2 Immunosuppressant’s
1.2.3 Anti-Inflammatory Drugs
1.2.4 Corticosteroids
1.2.5 Nonsteroidal Anti-inflammatory Drugs
1.2.6 Biologics
1.3 Market by Sale Channel
1.3.1 Global Autoimmune Disease Treatment Market Growth by Sale Channel: 2019 VS 2023 VS 2030
1.3.2 Hospitals
1.3.3 Clinics
1.3.4 Drug Stores
1.3.5 Other
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global Autoimmune Disease Treatment Market Perspective (2019-2030)
2.2 Autoimmune Disease Treatment Growth Trends by Region
2.2.1 Global Autoimmune Disease Treatment Market Size by Region: 2019 VS 2023 VS 2030
2.2.2 Autoimmune Disease Treatment Historic Market Size by Region (2019-2024)
2.2.3 Autoimmune Disease Treatment Forecasted Market Size by Region (2025-2030)
2.3 Autoimmune Disease Treatment Market Dynamics
2.3.1 Autoimmune Disease Treatment Industry Trends
2.3.2 Autoimmune Disease Treatment Market Drivers
2.3.3 Autoimmune Disease Treatment Market Challenges
2.3.4 Autoimmune Disease Treatment Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Autoimmune Disease Treatment Players by Revenue
3.1.1 Global Top Autoimmune Disease Treatment Players by Revenue (2019-2024)
3.1.2 Global Autoimmune Disease Treatment Revenue Market Share by Players (2019-2024)
3.2 Global Autoimmune Disease Treatment Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Autoimmune Disease Treatment Revenue
3.4 Global Autoimmune Disease Treatment Market Concentration Ratio
3.4.1 Global Autoimmune Disease Treatment Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Autoimmune Disease Treatment Revenue in 2023
3.5 Autoimmune Disease Treatment Key Players Head office and Area Served
3.6 Key Players Autoimmune Disease Treatment Product Solution and Service
3.7 Date of Enter into Autoimmune Disease Treatment Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Autoimmune Disease Treatment Breakdown Data by Type
4.1 Global Autoimmune Disease Treatment Historic Market Size by Type (2019-2024)
4.2 Global Autoimmune Disease Treatment Forecasted Market Size by Type (2025-2030)
5 Autoimmune Disease Treatment Breakdown Data by Sale Channel
5.1 Global Autoimmune Disease Treatment Historic Market Size by Sale Channel (2019-2024)
5.2 Global Autoimmune Disease Treatment Forecasted Market Size by Sale Channel (2025-2030)
6 North America
6.1 North America Autoimmune Disease Treatment Market Size (2019-2030)
6.2 North America Autoimmune Disease Treatment Market Growth Rate by Country: 2019 VS 2023 VS 2030
6.3 North America Autoimmune Disease Treatment Market Size by Country (2019-2024)
6.4 North America Autoimmune Disease Treatment Market Size by Country (2025-2030)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Autoimmune Disease Treatment Market Size (2019-2030)
7.2 Europe Autoimmune Disease Treatment Market Growth Rate by Country: 2019 VS 2023 VS 2030
7.3 Europe Autoimmune Disease Treatment Market Size by Country (2019-2024)
7.4 Europe Autoimmune Disease Treatment Market Size by Country (2025-2030)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Autoimmune Disease Treatment Market Size (2019-2030)
8.2 Asia-Pacific Autoimmune Disease Treatment Market Growth Rate by Region: 2019 VS 2023 VS 2030
8.3 Asia-Pacific Autoimmune Disease Treatment Market Size by Region (2019-2024)
8.4 Asia-Pacific Autoimmune Disease Treatment Market Size by Region (2025-2030)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Autoimmune Disease Treatment Market Size (2019-2030)
9.2 Latin America Autoimmune Disease Treatment Market Growth Rate by Country: 2019 VS 2023 VS 2030
9.3 Latin America Autoimmune Disease Treatment Market Size by Country (2019-2024)
9.4 Latin America Autoimmune Disease Treatment Market Size by Country (2025-2030)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Autoimmune Disease Treatment Market Size (2019-2030)
10.2 Middle East & Africa Autoimmune Disease Treatment Market Growth Rate by Country: 2019 VS 2023 VS 2030
10.3 Middle East & Africa Autoimmune Disease Treatment Market Size by Country (2019-2024)
10.4 Middle East & Africa Autoimmune Disease Treatment Market Size by Country (2025-2030)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Abbott Laboratories
11.1.1 Abbott Laboratories Company Detail
11.1.2 Abbott Laboratories Business Overview
11.1.3 Abbott Laboratories Autoimmune Disease Treatment Introduction
11.1.4 Abbott Laboratories Revenue in Autoimmune Disease Treatment Business (2019-2024)
11.1.5 Abbott Laboratories Recent Development
11.2 Active Biotech
11.2.1 Active Biotech Company Detail
11.2.2 Active Biotech Business Overview
11.2.3 Active Biotech Autoimmune Disease Treatment Introduction
11.2.4 Active Biotech Revenue in Autoimmune Disease Treatment Business (2019-2024)
11.2.5 Active Biotech Recent Development
11.3 Eli Lilly
11.3.1 Eli Lilly Company Detail
11.3.2 Eli Lilly Business Overview
11.3.3 Eli Lilly Autoimmune Disease Treatment Introduction
11.3.4 Eli Lilly Revenue in Autoimmune Disease Treatment Business (2019-2024)
11.3.5 Eli Lilly Recent Development
11.4 Bristol-Myers Squibb
11.4.1 Bristol-Myers Squibb Company Detail
11.4.2 Bristol-Myers Squibb Business Overview
11.4.3 Bristol-Myers Squibb Autoimmune Disease Treatment Introduction
11.4.4 Bristol-Myers Squibb Revenue in Autoimmune Disease Treatment Business (2019-2024)
11.4.5 Bristol-Myers Squibb Recent Development
11.5 AstraZeneca plc
11.5.1 AstraZeneca plc Company Detail
11.5.2 AstraZeneca plc Business Overview
11.5.3 AstraZeneca plc Autoimmune Disease Treatment Introduction
11.5.4 AstraZeneca plc Revenue in Autoimmune Disease Treatment Business (2019-2024)
11.5.5 AstraZeneca plc Recent Development
11.6 Pfizer
11.6.1 Pfizer Company Detail
11.6.2 Pfizer Business Overview
11.6.3 Pfizer Autoimmune Disease Treatment Introduction
11.6.4 Pfizer Revenue in Autoimmune Disease Treatment Business (2019-2024)
11.6.5 Pfizer Recent Development
11.7 Biogen Idec
11.7.1 Biogen Idec Company Detail
11.7.2 Biogen Idec Business Overview
11.7.3 Biogen Idec Autoimmune Disease Treatment Introduction
11.7.4 Biogen Idec Revenue in Autoimmune Disease Treatment Business (2019-2024)
11.7.5 Biogen Idec Recent Development
11.8 Lupin Limited
11.8.1 Lupin Limited Company Detail
11.8.2 Lupin Limited Business Overview
11.8.3 Lupin Limited Autoimmune Disease Treatment Introduction
11.8.4 Lupin Limited Revenue in Autoimmune Disease Treatment Business (2019-2024)
11.8.5 Lupin Limited Recent Development
11.9 GlaxoSmithKline
11.9.1 GlaxoSmithKline Company Detail
11.9.2 GlaxoSmithKline Business Overview
11.9.3 GlaxoSmithKline Autoimmune Disease Treatment Introduction
11.9.4 GlaxoSmithKline Revenue in Autoimmune Disease Treatment Business (2019-2024)
11.9.5 GlaxoSmithKline Recent Development
11.10 Amgen
11.10.1 Amgen Company Detail
11.10.2 Amgen Business Overview
11.10.3 Amgen Autoimmune Disease Treatment Introduction
11.10.4 Amgen Revenue in Autoimmune Disease Treatment Business (2019-2024)
11.10.5 Amgen Recent Development
11.11 4SC AG
11.11.1 4SC AG Company Detail
11.11.2 4SC AG Business Overview
11.11.3 4SC AG Autoimmune Disease Treatment Introduction
11.11.4 4SC AG Revenue in Autoimmune Disease Treatment Business (2019-2024)
11.11.5 4SC AG Recent Development
11.12 F. Hoffmann-La Roche Ltd.
11.12.1 F. Hoffmann-La Roche Ltd. Company Detail
11.12.2 F. Hoffmann-La Roche Ltd. Business Overview
11.12.3 F. Hoffmann-La Roche Ltd. Autoimmune Disease Treatment Introduction
11.12.4 F. Hoffmann-La Roche Ltd. Revenue in Autoimmune Disease Treatment Business (2019-2024)
11.12.5 F. Hoffmann-La Roche Ltd. Recent Development
11.13 AutoImmune Inc
11.13.1 AutoImmune Inc Company Detail
11.13.2 AutoImmune Inc Business Overview
11.13.3 AutoImmune Inc Autoimmune Disease Treatment Introduction
11.13.4 AutoImmune Inc Revenue in Autoimmune Disease Treatment Business (2019-2024)
11.13.5 AutoImmune Inc Recent Development
11.14 Johnson & Johnson
11.14.1 Johnson & Johnson Company Detail
11.14.2 Johnson & Johnson Business Overview
11.14.3 Johnson & Johnson Autoimmune Disease Treatment Introduction
11.14.4 Johnson & Johnson Revenue in Autoimmune Disease Treatment Business (2019-2024)
11.14.5 Johnson & Johnson Recent Development
11.15 Bayer
11.15.1 Bayer Company Detail
11.15.2 Bayer Business Overview
11.15.3 Bayer Autoimmune Disease Treatment Introduction
11.15.4 Bayer Revenue in Autoimmune Disease Treatment Business (2019-2024)
11.15.5 Bayer Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
